Commission Regulation (EU) 2024/996 of 3 April 2024 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use of Vitamin A, Alpha-Arbutin and Arbutin and certain substances with potential endocrine disrupting properties in cosmetic products
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XVI Cosmetics
Joint committee decision (JCD)
209/2024
In force in the EEA
Yes
Legal Documents
Commission Regulation (EU) 2024/996 of 3 April 2024 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use of Vitamin A, Alpha-Arbutin and Arbutin and certain substances with potential endocrine disrupting properties in cosmetic products
Reglugerð framkvæmdastjórnarinnar (ESB) 2024/996 frá 3. apríl 2024 um breytingu á reglugerð Evrópuþingsins og ráðsins (EB) nr. 1223/2009 að því er varðar notkun á A-vítamíni, alfaarbútíni og arbútíni og tilteknum efnum með hugsanlega innkirtlatruflandi eiginleika í snyrtivörur
Verordnung (EU) 2024/996 der Kommission vom 3. April 2024 zur Änderung der Verordnung (EG) Nr. 1223/2009 des Europäischen Parlaments und des Rates hinsichtlich der Verwendung von Vitamin A, Alpha-Arbutin und Arbutin sowie bestimmter Stoffe mit potenziell endokrinschädigenden Eigenschaften in kosmetischen Mitteln
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.